Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
miglitol | lysosomal alpha-glucosidase | small molecule | NA | drugbank , DGIDB | Diabetes Mellitus[MeSHID:D003920] Diet therapy[MeSHID:D004035] Hyperglycemia[MeSHID:D006943] Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Complications of Diabetes Mellitus[MeSHID:D048909] |
1.87 | approved | antagonist,inhibitor |
miglitol | lysosomal alpha-glucosidase | small molecule | NA | drugbank , DGIDB | Diabetes Mellitus[MeSHID:D003920] Diet therapy[MeSHID:D004035] Hyperglycemia[MeSHID:D006943] Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Complications of Diabetes Mellitus[MeSHID:D048909] |
1.87 | approved | antagonist |
miglitol | neutral alpha-glucosidase ab | small molecule | NA | drugbank | Diabetes Mellitus[MeSHID:D003920] Diet therapy[MeSHID:D004035] Hyperglycemia[MeSHID:D006943] Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Complications of Diabetes Mellitus[MeSHID:D048909] |
NA | approved | antagonist |
miglitol | neutral alpha-glucosidase c | small molecule | NA | drugbank | Diabetes Mellitus[MeSHID:D003920] Diet therapy[MeSHID:D004035] Hyperglycemia[MeSHID:D006943] Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Complications of Diabetes Mellitus[MeSHID:D048909] |
NA | approved | antagonist |
miglitol | intestinal maltase-glucoamylase | NA | Successful target | TTD , DGIDB | Diabetes Mellitus[MeSHID:D003920] Diet therapy[MeSHID:D004035] Hyperglycemia[MeSHID:D006943] Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Complications of Diabetes Mellitus[MeSHID:D048909] |
16.97 | approved | inhibitor |
miglitol | maltase-glucoamylase, intestinal | small molecule | NA | drugbank , DGIDB | Diabetes Mellitus[MeSHID:D003920] Diet therapy[MeSHID:D004035] Hyperglycemia[MeSHID:D006943] Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Complications of Diabetes Mellitus[MeSHID:D048909] |
16.97 | approved | antagonist,inhibitor |
miglitol | intestinal maltase-glucoamylase | NA | Successful target | TTD , DGIDB | Diabetes Mellitus[MeSHID:D003920] Diet therapy[MeSHID:D004035] Hyperglycemia[MeSHID:D006943] Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Complications of Diabetes Mellitus[MeSHID:D048909] |
16.97 | approved | unknown |
click here to return to the previous page |